Origasa, Hideki

Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis

Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2007) · The Lancet

Fatty Acid Research and HealthLipoproteins and Cardiovascular Health

Cited by 2,516

Japanese clinical practice guideline for diabetes 2019

Araki, E., Goto, A., Kondo, T., Noda, M., Noto, H., Origasa, H., Osawa, H., Taguchi, A., Tanizawa, Y., Tobe, K., et al. (2020) · Diabetology International

Diabetes Treatment and ManagementClinical practice guidelines implementation

Cited by 545

Prevalence of atrial fibrillation in the general population of Japan: An analysis based on periodic health examination

Inoue, H., Fujiki, A., Origasa, H., Ogawa, S., Okumura, K., Kubota, I., Aizawa, Y., Yamashita, T., Atarashi, H., Horie, M., et al. (2009) · International Journal of Cardiology

Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke Management

Cited by 432

Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: Sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS)

Saito, Y., Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2008) · Atherosclerosis

Fatty Acid Research and HealthLipoproteins and Cardiovascular Health

Cited by 316

Relationships between plasma fatty acid composition and coronary artery disease.

Itakura, H., Yokoyama, M., Matsuzaki, M., Saito, Y., Origasa, H., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Kita, T., et al. (2011) · Journal of Atherosclerosis and Thrombosis

Fatty Acid Research and HealthLipoproteins and Cardiovascular Health

Cited by 218

Reduction in the Recurrence of Stroke by Eicosapentaenoic Acid for Hypercholesterolemic Patients: Subanalysis of the JELIS Trial

Tanaka, K., Ishikawa, Y., Yokoyama, M., Origasa, H., Matsuzaki, M., Saito, Y., Matsuzawa, Y., Sasaki, J., Oikawa, S., Hishida, H., et al. (2008) · Stroke

Fatty Acid Research and HealthLipoproteins and Cardiovascular Health

Cited by 217

Evidence-based practice guideline for the treatment for diabetes in Japan 2013

Tajima, N., Noda, M., Origasa, H., Noto, H., Yabe, D., Fujita, Y., Goto, A., Fujimoto, K., Sakamoto, M., & Haneda, M. (2015) · Diabetology International

Diabetes Treatment and ManagementClinical practice guidelines implementation

Cited by 154

Suppressive effect of EPA on the incidence of coronary events in hypercholesterolemia with impaired glucose metabolism: Sub-analysis of the Japan EPA Lipid Intervention Study (JELIS)

Oikawa, S., Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Sasaki, J., Hishida, H., Itakura, H., et al. (2009) · Atherosclerosis

Fatty Acid Research and HealthLipoproteins and Cardiovascular Health

Cited by 125

Cardiovascular event rates in patients with cerebrovascular disease and atherothrombosis at other vascular locations: Results from 1-year outcomes in the Japanese REACH Registry

Uchiyama, S., Goto, S., Matsumoto, M., Nagai, R., Origasa, H., Yamazaki, T., Shigematsu, H., Shimada, K., Yamada, N., Bhatt, D. L., et al. (2009) · Journal of the Neurological Sciences

Acute Ischemic Stroke ManagementCerebrovascular and Carotid Artery Diseases

Cited by 59

The improvement of hypoxia correlates with neuroanatomic and developmental outcomes: Comparison of midterm outcomes in infants with transposition of the great arteries or single-ventricle physiology

Ibuki, K., Watanabe, K., Yoshimura, N., Kakimoto, T., Matsui, M., Yoshida, T., Origasa, H., & Ichida, F. (2012) · The Journal of Thoracic and Cardiovascular Surgery

Congenital Heart Disease StudiesCardiovascular Conditions and Treatments

Cited by 46

One-Year Cardiovascular Event Rates in Japanese Outpatients With Myocardial Infarction, Stroke, and Atrial Fibrillation: – Results From the Japan Thrombosis Registry for Atrial Fibrillation, Coronary, or Cerebrovascular Events (J-TRACE) –

Goto, S., Ikeda, Y., Shimada, K., Uchiyama, S., Origasa, H., Kobayashi, H., & The J-TRACE Investigators (2011) · Circulation Journal

Atrial Fibrillation Management and OutcomesAcute Myocardial Infarction Research

Cited by 35

Relationship between Coronary Artery Disease and Non-HDL-C, and Effect of Highly Purified EPA on the Risk of Coronary Artery Disease in Hypercholesterolemic Patients Treated with Statins: Sub-Analysis of the Japan EPA Lipid Intervention Study (JELIS)

Sasaki, J., Yokoyama, M., Matsuzaki, M., Saito, Y., Origasa, H., Ishikawa, Y., Oikawa, S., Itakura, H., Hishida, H., Kita, T., et al. (2012) · Journal of Atherosclerosis and Thrombosis

Lipoproteins and Cardiovascular HealthFatty Acid Research and Health

Cited by 35

Erratum to “Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: Sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS)” [Atherosclerosis 200 (2008) 135–140]

Saito, Y., Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2009) · Atherosclerosis

Fatty Acid Research and HealthLipoproteins and Cardiovascular Health

Cited by 29